{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:46:44Z","timestamp":1791474404479,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key R & D project of Jiangsu Province","award":["BE2020708"],"award-info":[{"award-number":["BE2020708"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82273066"],"award-info":[{"award-number":["82273066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spindle and kinetochore-associated complex subunit 3 (SKA3) plays an important role in cell proliferation by regulating the separation of chromosomes and their division into daughter cells. Previous studies demonstrated that SKA3 was strongly implicated in tumor development and progression. However, the roles of SKA3 in cholangiocarcinoma (CCA) and the underlying mechanisms remain unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Next-generation sequencing (NGS) was performed with paired CCA tissues and normal adjacent tissues (NATs). SKA3 was chose to be the target gene because of its remarkably upregulation and unknown function in cholangiocarcinoma in TCGA datasets, GSE107943 datasets and our sequencing results. RT-PCR and immunohistochemistry staining were used to detect the expression of SKA3 in paired CCA tissues and normal adjacent tissues. The SKA3 knockdown and overexpression cell line were constructed by small interfering RNA and lentivirus vector transfection. The effect of SKA3 on the proliferation of cholangiocarcinoma under hypoxic conditions was detected by experiments in vitro and in vivo. RNA-seq was used to find out the differentially expressed pathways in cholangiocarcinoma proliferation under hypoxia regulated by SKA3. IP\/MS analysis and Western blot assays were used to explore the specific mechanism of SKA3 in regulating the expression of HIF-1a under hypoxia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>SKA3 was up-regulated in NGS, TCGA and GSE107943 databases and was associated with poor prognosis. Functional experiments in vitro and in vivo showed that hypoxia-induced SKA3 promoted cholangiocarcinoma cell proliferation. RNA-sequencing was performed and verified that SKA3 enhanced fatty acid synthesis by up-regulating the expression of key fatty acid synthase, thus promoting cholangiocarcinoma cell proliferation under hypoxic conditions. Further studies indicated that under hypoxic conditions, SKA3 recruited PARP1 to bind to HIF-1a, thus enhancing the poly ADP-ribosylation (PARylation) of HIF-1a. This PARylation enhanced the binding between HIF-1a and USP7, which triggered the deubiquitylation of HIF-1a under hypoxic conditions. Additionally, PARP1 and HIF-1a were upregulated in CCA and promoted CCA cell proliferation. SKA3 promoted CCA cell proliferation and fatty acid synthesis via the PARP1\/HIF-1a axis under hypoxic conditions. High SKA3 and HIF-1a expression levels were associated with poor prognosis after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Hypoxia-induced SKA3 promoted CCA progression by enhancing fatty acid synthesis via the regulation of PARylation-dependent HIF-1a deubiquitylation. Furthermore, increased SKA3 level enhanced chemotherapy-resistance to gemcitabine-based regimen under hypoxic conditions. SKA3 and HIF-1a could be potential oncogenes and significant biomarkers for the analysis of CCA patient prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-023-02842-7","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T04:02:38Z","timestamp":1696996958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation"],"prefix":"10.1186","volume":"42","author":[{"given":"Yananlan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuochen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangcheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"issue":"9","key":"2842_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"2842_CR2","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/cncr.32803","volume":"126","author":"AA Florio","year":"2020","unstructured":"Florio AA, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666\u201378.","journal-title":"Cancer"},{"issue":"9","key":"2842_CR3","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.ejso.2019.04.002","volume":"45","author":"E Alabraba","year":"2019","unstructured":"Alabraba E, et al. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged. Eur J Surg Oncol. 2019;45(9):1660\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"2842_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/SLA.0000000000003801","volume":"273","author":"WA Cambridge","year":"2021","unstructured":"Cambridge WA, et al. Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma. Ann Surg. 2021;273(2):240\u201350.","journal-title":"Ann Surg"},{"issue":"10","key":"2842_CR5","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/emboj.2009.96","volume":"28","author":"TN Gaitanos","year":"2009","unstructured":"Gaitanos TN, et al. Stable kinetochore-microtubule interactions depend on the Ska complex and its new component Ska3\/C13Orf3. Embo j. 2009;28(10):1442\u201352.","journal-title":"Embo j"},{"issue":"Pt 14","key":"2842_CR6","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1242\/jcs.051912","volume":"122","author":"JA Raaijmakers","year":"2009","unstructured":"Raaijmakers JA, et al. RAMA1 is a novel kinetochore protein involved in kinetochore-microtubule attachment. J Cell Sci. 2009;122(Pt 14):2436\u201345.","journal-title":"J Cell Sci"},{"issue":"17","key":"2842_CR7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.cub.2009.07.017","volume":"19","author":"JR Daum","year":"2009","unstructured":"Daum JR, et al. Ska3 is required for spindle checkpoint silencing and the maintenance of chromosome cohesion in mitosis. Curr Biol. 2009;19(17):1467\u201372.","journal-title":"Curr Biol"},{"issue":"10","key":"2842_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/emboj.2009.114","volume":"28","author":"M Theis","year":"2009","unstructured":"Theis M, et al. Comparative profiling identifies C13orf3 as a component of the Ska complex required for mammalian cell division. Embo j. 2009;28(10):1453\u201365.","journal-title":"Embo j"},{"issue":"12","key":"2842_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41419-019-2163-3","volume":"10","author":"Y Hou","year":"2019","unstructured":"Hou Y, et al. SKA3 Promotes tumor growth by regulating CDK2\/P53 phosphorylation in hepatocellular carcinoma. Cell Death Dis. 2019;10(12):929.","journal-title":"Cell Death Dis"},{"key":"2842_CR10","doi-asserted-by":"publisher","first-page":"101885","DOI":"10.1016\/j.redox.2021.101885","volume":"41","author":"JM Mart\u00ed","year":"2021","unstructured":"Mart\u00ed JM, et al. Selective modulation by PARP-1 of HIF-1\u03b1-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions. Redox Biol. 2021;41:101885.","journal-title":"Redox Biol"},{"key":"2842_CR11","doi-asserted-by":"crossref","unstructured":"Yehya AHS, et al. Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis. Medicina (Kaunas). 2018;54(1):8.","DOI":"10.3390\/medicina54010008"},{"issue":"2","key":"2842_CR12","first-page":"469","volume":"53","author":"WW Tong","year":"2018","unstructured":"Tong WW, Tong GH, Liu Y. Cancer stem cells and hypoxia-inducible factors (Review). Int J Oncol. 2018;53(2):469\u201376.","journal-title":"Int J Oncol"},{"issue":"1","key":"2842_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbcan.2018.07.002","volume":"1870","author":"D Samanta","year":"2018","unstructured":"Samanta D, Semenza GL. Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors. Biochim Biophys Acta Rev Cancer. 2018;1870(1):15\u201322.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2842_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.lfs.2019.03.056","volume":"224","author":"R Ezzeddini","year":"2019","unstructured":"Ezzeddini R, et al. Clinical importance of FASN in relation to HIF-1\u03b1 and SREBP-1c in gastric adenocarcinoma. Life Sci. 2019;224:169\u201376.","journal-title":"Life Sci"},{"issue":"6733","key":"2842_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399(6733):271\u20135.","journal-title":"Nature"},{"issue":"30","key":"2842_CR16","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1038\/onc.2017.8","volume":"36","author":"MC Lin","year":"2017","unstructured":"Lin MC, et al. GATA3 interacts with and stabilizes HIF-1\u03b1 to enhance cancer cell invasiveness. Oncogene. 2017;36(30):4243\u201352.","journal-title":"Oncogene"},{"issue":"6","key":"2842_CR17","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1074\/jbc.M109.068577","volume":"285","author":"W Luo","year":"2010","unstructured":"Luo W, et al. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J Biol Chem. 2010;285(6):3651\u201363.","journal-title":"J Biol Chem"},{"issue":"12","key":"2842_CR18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrc2540","volume":"8","author":"JA Bertout","year":"2008","unstructured":"Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer. 2008;8(12):967\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2842_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrm3376","volume":"13","author":"BA Gibson","year":"2012","unstructured":"Gibson BA, Kraus WL. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol. 2012;13(7):411\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"2842_CR20","doi-asserted-by":"publisher","first-page":"e1007394","DOI":"10.1371\/journal.ppat.1007394","volume":"14","author":"M Hulse","year":"2018","unstructured":"Hulse M, et al. Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1. PLoS Pathog. 2018;14(11):e1007394.","journal-title":"PLoS Pathog"},{"key":"2842_CR21","doi-asserted-by":"publisher","first-page":"e11067","DOI":"10.7717\/peerj.11067","volume":"9","author":"P Sungwan","year":"2021","unstructured":"Sungwan P, et al. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. PeerJ. 2021;9:e11067.","journal-title":"PeerJ"},{"issue":"3","key":"2842_CR22","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.18632\/aging.102766","volume":"12","author":"L Guo","year":"2020","unstructured":"Guo L, et al. Screening and identification of genes associated with cell proliferation in cholangiocarcinoma. Aging (Albany NY). 2020;12(3):2626\u201346.","journal-title":"Aging (Albany NY)"},{"issue":"21","key":"2842_CR23","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2842_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.trecan.2019.08.005","volume":"5","author":"D Mennerich","year":"2019","unstructured":"Mennerich D, Kubaichuk K, Kietzmann T. DUBs, Hypoxia, and Cancer. Trends Cancer. 2019;5(10):632\u201353.","journal-title":"Trends Cancer"},{"issue":"7","key":"2842_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nm1440","volume":"12","author":"CR Jung","year":"2006","unstructured":"Jung CR, et al. E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med. 2006;12(7):809\u201316.","journal-title":"Nat Med"},{"issue":"1","key":"2842_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s13046-021-02143-x","volume":"40","author":"Q Li","year":"2021","unstructured":"Li Q, et al. Lnc-RP11\u2013536 K7.3\/SOX2\/HIF-1\u03b1 signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. J Exp Clin Cancer Res. 2021;40(1):348.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2842_CR27","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1038\/s41467-021-25252-9","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, et al. PARylation prevents the proteasomal degradation of topoisomerase I DNA-protein crosslinks and induces their deubiquitylation. Nat Commun. 2021;12(1):5010.","journal-title":"Nat Commun"},{"key":"2842_CR28","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1038\/ncomms11960","volume":"7","author":"X Gao","year":"2016","unstructured":"Gao X, et al. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat Commun. 2016;7:11960.","journal-title":"Nat Commun"},{"key":"2842_CR29","doi-asserted-by":"crossref","unstructured":"Melana JP, et al. The Hypoxic Microenvironment Induces Stearoyl-CoA Desaturase-1 Overexpression and Lipidomic Profile Changes in Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2021;13(12):2962.","DOI":"10.3390\/cancers13122962"},{"issue":"7","key":"2842_CR30","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/stem.2020","volume":"33","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, et al. Novel pathway for hypoxia-induced proliferation and migration in human mesenchymal stem cells: involvement of HIF-1\u03b1, FASN, and mTORC1. Stem Cells. 2015;33(7):2182\u201395.","journal-title":"Stem Cells"},{"issue":"6","key":"2842_CR31","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12282-016-0683-6","volume":"23","author":"M Singh","year":"2016","unstructured":"Singh M, et al. Prolyl hydroxylase mediated inhibition of fatty acid synthase to combat tumor growth in mammary gland carcinoma. Breast Cancer. 2016;23(6):820\u20139.","journal-title":"Breast Cancer"},{"key":"2842_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12967-015-0732-5","volume":"13","author":"E Garc\u00eda-Fuentes","year":"2015","unstructured":"Garc\u00eda-Fuentes E, et al. Hypoxia is associated with a lower expression of genes involved in lipogenesis in visceral adipose tissue. J Transl Med. 2015;13:373.","journal-title":"J Transl Med"},{"issue":"10","key":"2842_CR33","doi-asserted-by":"publisher","first-page":"13581","DOI":"10.1007\/s13277-016-5279-4","volume":"37","author":"TR Stoyanoff","year":"2016","unstructured":"Stoyanoff TR, et al. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO\/EPO-R system and hypoxia-related proteins. Tumour Biol. 2016;37(10):13581\u201393.","journal-title":"Tumour Biol"},{"issue":"17","key":"2842_CR34","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41388-023-02661-2","volume":"42","author":"W Jiang","year":"2023","unstructured":"Jiang W, et al. KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1\/YBX1 mediated NF-\u03baB pathway in cholangiocarcinoma. Oncogene. 2023;42(17):1392\u2013404.","journal-title":"Oncogene"},{"issue":"20","key":"2842_CR35","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1158\/0008-5472.CAN-16-3062","volume":"77","author":"S Tadros","year":"2017","unstructured":"Tadros S, et al. De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer. Cancer Res. 2017;77(20):5503\u201317.","journal-title":"Cancer Res"},{"issue":"6","key":"2842_CR36","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1242\/dmm.011338","volume":"6","author":"F Baenke","year":"2013","unstructured":"Baenke F, et al. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech. 2013;6(6):1353\u201363.","journal-title":"Dis Model Mech"},{"issue":"4","key":"2842_CR37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/01.mco.0000232894.28674.30","volume":"9","author":"JV Swinnen","year":"2006","unstructured":"Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care. 2006;9(4):358\u201365.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"2842_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jhep.2008.07.036","volume":"50","author":"T Yamashita","year":"2009","unstructured":"Yamashita T, et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol. 2009;50(1):100\u201310.","journal-title":"J Hepatol"},{"issue":"10","key":"2842_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"2842_CR40","doi-asserted-by":"publisher","first-page":"9199","DOI":"10.1111\/jcmm.16815","volume":"25","author":"J Chen","year":"2021","unstructured":"Chen J, et al. CCAT1\/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K\/AKT\/mTOR signalling in lung adenocarcinoma. J Cell Mol Med. 2021;25(19):9199\u2013213.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2842_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1389450115666141224125117","volume":"16","author":"AD Khwairakpam","year":"2015","unstructured":"Khwairakpam AD, et al. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment. Curr Drug Targets. 2015;16(2):156\u201363.","journal-title":"Curr Drug Targets"},{"issue":"2","key":"2842_CR42","first-page":"515","volume":"2","author":"C Wang","year":"2010","unstructured":"Wang C, et al. Acetyl-CoA carboxylase-a as a novel target for cancer therapy. Front Biosci (Schol Ed). 2010;2(2):515\u201326.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"5","key":"2842_CR43","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1053\/j.gastro.2013.01.054","volume":"144","author":"A Budhu","year":"2013","unstructured":"Budhu A, et al. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology. 2013;144(5):1066-1075.e1.","journal-title":"Gastroenterology"},{"issue":"9","key":"2842_CR44","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ejca.2004.12.037","volume":"41","author":"N Yahagi","year":"2005","unstructured":"Yahagi N, et al. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer. 2005;41(9):1316\u201322.","journal-title":"Eur J Cancer"},{"issue":"16","key":"2842_CR45","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","volume":"19","author":"K Tanimoto","year":"2000","unstructured":"Tanimoto K, et al. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. Embo J. 2000;19(16):4298\u2013309.","journal-title":"Embo J"},{"issue":"6","key":"2842_CR46","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/cbin.11574","volume":"45","author":"YC Xu","year":"2021","unstructured":"Xu YC, et al. RACK1 mediates the advanced glycation end product-induced degradation of HIF-1\u03b1 in nucleus pulposus cells via competing with HSP90 for HIF-1\u03b1 binding. Cell Biol Int. 2021;45(6):1316\u201326.","journal-title":"Cell Biol Int"},{"key":"2842_CR47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-60761-738-9_13","volume":"647","author":"EY Dimova","year":"2010","unstructured":"Dimova EY, Kietzmann T. Hypoxia-inducible factors: post-translational crosstalk of signaling pathways. Methods Mol Biol. 2010;647:215\u201336.","journal-title":"Methods Mol Biol"},{"issue":"Pt 2","key":"2842_CR48","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/bj3420249","volume":"342","author":"D D'Amours","year":"1999","unstructured":"D\u2019Amours D, et al. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J. 1999;342(Pt 2):249\u201368.","journal-title":"Biochem J"},{"key":"2842_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bcp.2019.05.006","volume":"167","author":"CA Vivelo","year":"2019","unstructured":"Vivelo CA, Ayyappan V, Leung AKL. Poly(ADP-ribose)-dependent ubiquitination and its clinical implications. Biochem Pharmacol. 2019;167:3\u201312.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2842_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bcp.2014.06.021","volume":"92","author":"F Aredia","year":"2014","unstructured":"Aredia F, Scovassi AI. Poly(ADP-ribose): a signaling molecule in different paradigms of cell death. Biochem Pharmacol. 2014;92(1):157\u201363.","journal-title":"Biochem Pharmacol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-023-02842-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T11:03:55Z","timestamp":1700478235000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-023-02842-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2842"],"URL":"https:\/\/doi.org\/10.1186\/s13046-023-02842-7","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"4 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments on animals were approved by the Institutional Animal Care and Use Committee of Nanjing Medical University under IACUC approval No. 2203004.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"265"}}